Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease. [electronic resource]
Producer: 20040319Description: 141-7 p. digitalISSN:- 0392-9590
- Aged
- Aged, 80 and over
- Arterial Occlusive Diseases -- blood
- Blood Gas Monitoring, Transcutaneous
- Blood Pressure -- physiology
- Diastole -- physiology
- Double-Blind Method
- Female
- Foot -- blood supply
- Humans
- Immunotherapy
- Ischemia -- blood
- Male
- Microcirculation -- physiology
- Middle Aged
- Peripheral Vascular Diseases -- blood
- Pilot Projects
- Recovery of Function -- physiology
- Regional Blood Flow -- physiology
- Skin -- blood supply
- Sweden
- Systole -- physiology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.